eli lilly glp-1 drugs to seek approval of new weight-loss drug this year Eli Lilly's Obesity Pill Appears
Description
The neuroprotective effect of exendin-4 was found to be independent of the glucose-increasing effect, whereas related to increasing the levels of cAMP and reducing oxidative stress and the inflammatory response (83)
Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes
Known as gliptins these drugs have proven helpful to lowering blood sugar levels in people with type 2 diabetes
It can also be significantly impacted by social, economic, and environmental challenges that individuals may face like limited health education, financial constraints, and lack of social support
doi: 10.1001/jamainternmed.2013.2720
In response to nutrients, enteroendocrine L-cells and K-cells produce and release the incretin hormones including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), respectively [2]
